The 11th Conference on Liquid Biopsy【Tokyo】

科学・医療分野の学会で、研究者がスクリーンを使って研究成果を発表し、参加者が聴講する様子
             

Event Details

  • Date: –

Liquid Biopsy / Cancer Diagnostics / Tokyo

The 11th Conference on Liquid Biopsy [Tokyo]

The 11th Conference on Liquid Biopsy will be held on February 5–6, 2027, at Keio Plaza Hotel Tokyo. With the Japanese-language theme “社会実装へ向けたパラダイムシフト” (Paradigm Shift Toward Real-World Implementation), the meeting invites research on liquid biopsy technologies and their applications, including cell-free DNA (cfDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs).

Date
February 5 (Fri)–6 (Sat), 2027
Venue
Keio Plaza Hotel Tokyo
Chief Organizer
Satoshi Nishizuka
Theme
Paradigm Shift Toward Real-World Implementation

Meeting Theme

Paradigm Shift Toward Real-World Implementation (English translation of the Japanese theme “社会実装へ向けたパラダイムシフト”)

Event Information

  • Official English title: The 11th Conference on Liquid Biopsy
  • Japanese title: 第11回Liquid Biopsy研究会
  • Dates: February 5 (Friday)–6 (Saturday), 2027
  • Venue:Keio Plaza Hotel Tokyo
  • Address: 2-2-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-8330, Japan
  • Organizing society: Japanese Society for the Study of Liquid Biopsy

Organization

  • Chief Organizer: Satoshi Nishizuka, Professor, Institute for Biomedical Sciences, Iwate Medical University
  • Society Representative: Wataru Obara, Department of Urology, Iwate Medical University
  • Secretariat: Department of Urology, Kyorin University School of Medicine
  • Secretariat address: 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
  • Contact:liquidbiopsy@ks.kyorin-u.ac.jp

General Abstract Submission (Closed)

  • Submission period: August 3 (Monday)–October 9 (Friday), 2026, noon
  • Areas: Liquid biopsy technologies and applications involving cfDNA, CTCs, EVs, and related topics
  • Submission system: A-Pass (formerly Confit)
  • Status: General abstract submission is closed

The deadline was extended to October 9, 2026, at noon. For the official instructions, see the Abstract Submission Guide (Japanese).

Invited and Sponsored Session Abstracts

  • Eligible sessions: Lectures, symposia, luncheon and evening seminars, and sponsored sessions
  • Submission period: October 20 (Tuesday), 2026, noon–November 10 (Tuesday), 2026, noon
  • Submission system: A-Pass (formerly Confit)
  • English abstracts: Title up to 300 half-width characters; body up to 2,400 half-width characters
  • Japanese abstracts: Title up to 70 full-width characters; body up to 600 full-width characters

For submission rules, see the official instructions (Japanese). The English abstract submission portal is linked from the official site. This registration is separate from the closed general abstract submission.

Research Areas

  • Cell-free DNA (cfDNA): technologies and applications
  • Circulating tumor cells (CTCs): technologies and applications
  • Extracellular vesicles (EVs): technologies and applications
  • Other liquid biopsy technologies and applications

Overview

The meeting provides a forum for research on liquid biopsy technologies and their applications. The 2027 meeting is organized around a theme of moving these approaches toward real-world implementation. Applications using cfDNA, CTCs, and EVs are among the areas covered by the official call for abstracts.

Program & Participant Registration

As of November 4, 2026, details of the lecture program, general participant registration, and registration fees could not be confirmed on the official meeting pages. Please refer to the official English meeting page for the available information and any updates.

Getting to the Venue

  • Shinjuku Station: Approximately 5 minutes on foot from the West Exit (JR, private railways, and subway lines)
  • Tocho-mae Station (Toei Oedo Line): Immediately accessible from Exit A1 (B1 level)
  • Address: 2-2-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-8330, Japan

Visit the official Keio Plaza Hotel Tokyo access page (English) for directions.